Intelligent Bio Solutions Inc (INBS): Market Cap to Revenue

Symbol and logo of brand Intelligent Bio (INBS)

Intelligent Bio Solutions (INBS) utilizes unique sweat-based testing systems that create customer dependency on consumables, although sales volumes remain limited. The volatility of the P/S ratio reflects market demand, where 1.40 shows the current value of the metric. Business stability is guaranteed by mandatory employer demand regardless of crises. Effective distribution through medical networks and warehouse processing ensure the uninterrupted supply of portable devices.

INBS Intelligent Bio P/S Multiple (04/28/2023 - 11/13/2026)

Analytical breakdowns for Intelligent Bio Solutions (INBS)

- share price and consensus valuation forecast:
Price Performance Chart ibs.inc|INBS - Price Target Chart
- stock exchange capitalization data:
Market Valuation Intelligent Bio|INBS - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Intelligent Bio Solutions|INBS - Book Capitalization|Capitalization to Book Value Ratio ibs.inc|INBS - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Intelligent Bio Solutions|INBS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio ibs.inc|INBS - Company Aggregate Debts|Debts to Book Capitalization Intelligent Bio|INBS - Company Long-Term Debt|Company Short-Term Debt Intelligent Bio Solutions|Intermediate Coverage Ratio ibs.inc
- earnings and multiples data:
INBS - Net Profit|Expected Net Profit Intelligent Bio Solutions|INBS - Price to Earnings Ratio|Forward Price to Earnings Multiple ibs.inc|INBS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Intelligent Bio|INBS - Operating profit EBITDA|Net earnings per share for the last four quarters Intelligent Bio Solutions|INBS - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ibs.inc|INBS - Earnings per share growth in current year|Expected earnings per share growth for next year Intelligent Bio Solutions
- issuer revenue and sales details:
INBS - Revenue and Sales Volume|Company Expected Sales Volume ibs.inc|INBS - Price-to-Revenue Ratio|Market Cap to Projected Revenue Intelligent Bio
General company analysis:INBS Intelligent Bio Solutions Inc
Core merchandise of Intelligent Bio Solutions Inc.

A conservative approach to analyzing Intelligent Bio Solutions (INBS) requires comparing market value with actual revenues. This metric is calculated as the ratio of market capitalization to annual revenue, determining the price of each unit of sales. The average P/S trend for Intelligent Bio Solutions (INBS) on this chart reflects market expectations for the commercialization of rapid diagnostic systems developed by the team of engineers and medical professionals. High values indicate an innovation premium but increase the risk of a correction should growth slow.

Competitors of Intelligent Bio Solutions

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|SSKN - Price-to-Revenue Coefficient|Price-to-Revenue Ratio GlucoTrack, Inc.|Market Cap to Revenue Ratio NAOV (nanovibronix.com)|Market Cap to Revenue VERO (Venus Concept Corp)|Market Cap to Sales Volume NUWE|P/S Multiple AEMD (Aethlon Medical)|Asensus Surgical Inc (ASXC) - Price to Sales|AVGR - Price-to-Revenue Ratio|BSGM: Price-to-Revenue Ratio|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|KNW (Know Labs Corporation) - Price-to-Revenue Ratio|NARI (Inari Medical, Inc.) - P/S Multiple|nevro.com (NVRO) - Price-to-Revenue Coefficient|P/S Multiple RSLS|Silk Road Medical, Inc. (SILK) - Price-to-Revenue Multiple